RxSight
RXST
214 hedge funds and large institutions have $1.68B invested in RxSight in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 89 increasing their positions, 65 reducing their positions, and 45 closing their positions.
1,355% more call options, than puts
Call options by funds: $23.1M | Put options by funds: $1.59M
37% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 65
1.01% more ownership
Funds ownership: 84.53% → 85.54% (+1%)
6% less funds holding
Funds holding: 228 → 214 (-14)
15% less capital invested
Capital invested by funds: $1.98B → $1.68B (-$305M)
29% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 45
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$50.8M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$35M |
| 3 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$27.8M |
| 4 |
BlackRock
New York
|
+$19.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$35.1M |
| 2 |
Morgan Stanley
New York
|
-$32.3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$19.5M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$15.5M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$13.9M |
RXST Hedge Fund Activity: Q3 2024 in Review
214 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q3 2024, worth a combined $1.68B — down 15% from $1.98B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of RXST and 32 opened new positions — a net loss of 13 holders — while 65 trimmed existing stakes and 89 added.
The largest buyer was Bank of America, adding an estimated $50.8M. The largest seller was Lord, Abbett & Co, cutting an estimated $35.1M.
- 214 institutional investors held RxSight (RXST) as of Q3 2024, down from 228 in Q2 2024.
- Funds reported $1.68B of RxSight stock for Q3 2024, down 15% quarter-over-quarter.
- 32 funds opened new RxSight positions in Q3 2024 and 45 closed out, a net change of -13 holders.
- The largest RxSight buyer in Q3 2024 was Bank of America, an estimated $50.8M added.
- The largest RxSight seller in Q3 2024 was Lord, Abbett & Co, an estimated $35.1M sold.
Based on aggregated 13F filings for Q3 2024.